Patents by Inventor Axel Rolf Zander

Axel Rolf Zander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF TRI-SUBSTITUTED GLYCEROL COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
    Publication number: 20130266591
    Abstract: The present invention relates to the use of a tri-substituted glycerol compound for the manufacture of a medicament for the treatment of hematological malignancies. The invention also refers to a kit-of-parts comprising such a medicament. Finally, the invention also relates to a corresponding method for the treatment of such conditions as well as to an in vitro method for determining the susceptibility of such malignant cells to a medicament as defined in the invention.
    Type: Application
    Filed: June 5, 2013
    Publication date: October 10, 2013
    Inventors: Axel Rolf Zander, Francis Ayuk Ayuketang, Wolfgang Richter, Lutz Weber
  • METHOD FOR PURIFYING MESENCHYMAL STEM CELLS
    Publication number: 20110195497
    Abstract: The invention relates to a method for purifying mesenchymal stem cells, producing cells corresponding to prior art, the cells obtained being characterised by an increased proliferation capacity while maintaining the multipotency and typical antigen characteristics. To this end, mesenchymal stem cells that can be multiplied in a significantly improved manner compared to prior art are first provided and can also be differentiated, after a longer cultivation period, in three mesenchymal directions.
    Type: Application
    Filed: November 15, 2010
    Publication date: August 11, 2011
    Inventors: Claudia Lange, Axel Rolf Zander
  • Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
    Publication number: 20100136029
    Abstract: The present invention relates to the use of a tri-substituted glycerol compound for the manufacture of a medicament for the treatment of hematological malignancies. The invention also refers to a kit-of-parts comprising such a medicament. Finally, the invention also relates to a corresponding method for the treatment of such conditions as well as to an in vitro method for determining the susceptibility of such malignant cells to a medicament as defined in the invention.
    Type: Application
    Filed: November 9, 2007
    Publication date: June 3, 2010
    Applicants: UNIVERSITATSKLINIKUM HAMBURG-EPPENDORF, ALPHAPTOSE GMBH
    Inventors: Axel Rolf Zander, Francis Ayuk Ayuketang, Wolfgang Richter, Lutz Weber